David Santos
Corporate Officer/Principal presso RIGEL PHARMACEUTICALS, INC.
Patrimonio netto: 384 002 $ in data 30/04/2024
Profilo
David A.
Santos currently works at Rigel Pharmaceuticals, Inc., as Chief Commercial Officer & Executive VP from 2020.
Mr. Santos also formerly worked at Amgen, Inc., as Vice President-Kinase Inhibitor, Pfizer Inc., as Vice President-Sales & Marketing, and Jazz Pharmaceuticals, Inc., as Head-Hematology.
Mr. Santos received his undergraduate degree from St. Louis University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 28/02/2024 | 349 093 ( 0.20% ) | 384 002 $ | 30/04/2024 |
Posizioni attive di David Santos
| Società | Posizione | Inizio |
|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2020 |
Precedenti posizioni note di David Santos
| Società | Posizione | Fine |
|---|---|---|
| PFIZER, INC. | Vendite & Marketing | - |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Formazione di David Santos
| St. Louis University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
- Borsa valori
- Insiders
- David Santos
